Replimune Net Receivables from 2010 to 2024

REPL Stock  USD 7.90  0.79  11.11%   
Replimune Net Receivables yearly trend continues to be quite stable with very little volatility. The value of Net Receivables is projected to decrease to about 3.2 M. From the period between 2010 and 2024, Replimune, Net Receivables regression line of its data series had standard deviation of  1,038,649 and standard deviation of  1,038,649. View All Fundamentals
 
Net Receivables  
First Reported
2017-03-31
Previous Quarter
4.3 M
Current Value
4.9 M
Quarterly Volatility
815.3 K
 
Covid
Check Replimune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Replimune's main balance sheet or income statement drivers, such as Interest Income of 935.8 K, Depreciation And Amortization of 1.4 M or Interest Expense of 1.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.44. Replimune financial statements analysis is a perfect complement when working with Replimune Valuation or Volatility modules.
  
Check out the analysis of Replimune Correlation against competitors.

Latest Replimune's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Replimune Group over the last few years. It is Replimune's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Replimune's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Replimune Net Receivables Regression Statistics

Arithmetic Mean2,314,626
Geometric Mean2,121,228
Coefficient Of Variation44.87
Mean Deviation847,117
Median2,389,000
Standard Deviation1,038,649
Sample Variance1.1T
Range3.5M
R-Value0.87
Mean Square Error283.5B
R-Squared0.76
Significance0.000025
Slope201,938
Total Sum of Squares15.1T

Replimune Net Receivables History

20243.2 M
20234.9 M
20222.9 M
20213.1 M
2020M
2019M
20182.5 M

About Replimune Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Replimune income statement, its balance sheet, and the statement of cash flows. Replimune investors use historical funamental indicators, such as Replimune's Net Receivables, to determine how well the company is positioned to perform in the future. Although Replimune investors may use each financial statement separately, they are all related. The changes in Replimune's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Replimune's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Replimune Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Replimune. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables4.9 M3.2 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Replimune Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Replimune Stock

When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out the analysis of Replimune Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.24)
Return On Assets
(0.26)
Return On Equity
(0.46)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.